Seroneutralization of porcine reproductive and respiratory syndrome virus correlates with antibody response to the GP5 major envelope glycoprotein.
about
Immunological features of the non-structural proteins of porcine reproductive and respiratory syndrome virusThe role of porcine reproductive and respiratory syndrome (PRRS) virus structural and non-structural proteins in virus pathogenesis.Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain.Comparative measurement of cell-mediated immune responses of swine to the M and N proteins of porcine reproductive and respiratory syndrome virus.Serodiagnosis of porcine reproductive and respiratory syndrome virus infection with the use of glycoprotein 5 antigens.Species-specific monoclonal antibodies to Escherichia coli-expressed p36 cytosolic protein of Mycoplasma hyopneumoniaeImmune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus.Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5.Evolution of porcine reproductive and respiratory syndrome virus during sequential passages in pigs.Signal peptide cleavage from GP5 of PRRSV: a minor fraction of molecules retains the decoy epitope, a presumed molecular cause for viral persistence.The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods.Use of adenoviral vectors as veterinary vaccines.Immunogenic and protective properties of GP5 and M structural proteins of porcine reproductive and respiratory syndrome virus expressed from replicating but nondisseminating adenovectors.Evaluation of the Cross-Protective Efficacy of a Chimeric Porcine Reproductive and Respiratory Syndrome Virus Constructed Based on Two Field Strains.Evaluation of the new commercial recombinant chimeric subunit vaccine PRRSFREE in challenge with heterologous types 1 and 2 porcine reproductive and respiratory syndrome virus.Mouse models of diseases of megakaryocyte and platelet homeostasis.Epidemiological investigations of the introduction of porcine reproductive and respiratory syndrome virus in Chile, 2013-2015.Production and evaluation of virus-like particles displaying immunogenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV)A subset of porcine reproductive and respiratory syndrome virus GP3 glycoprotein is released into the culture medium of cells as a non-virion-associated and membrane-free (soluble) form.Heterodimerization of the two major envelope proteins is essential for arterivirus infectivity.Molecular mutations associated with the in vitro passage of virulent porcine reproductive and respiratory syndrome virus.ORF1a of highly pathogenic PRRS attenuated vaccine virus plays a key role in neutralizing antibody induction in piglets and virus neutralization in vitro.Highly virulent porcine reproductive and respiratory syndrome virus emerged in China.Immunopotentiation of four natural adjuvants co-administered with a highly pathogenic porcine reproductive and respiratory syndrome virus glycoprotein 5 subunit.A novel isolate with deletion in GP3 gene of porcine reproductive and respiratory syndrome virus from mid-eastern China.A variable region in GP4 of European-type porcine reproductive and respiratory syndrome virus induces neutralizing antibodies against homologous but not heterologous virus strains.Molecular assessment of the role of envelope-associated structural proteins in cross neutralization among different PRRS viruses.Genetic diversity of the ORF5 gene of porcine reproductive and respiratory syndrome virus (PRRSV) genotypes I and II in Thailand.Construction and immunogenicity of DNA vaccines encoding fusion protein of porcine IFN- λ 1 and GP5 gene of porcine reproductive and respiratory syndrome virus.Novel analytic tools for the study of porcine reproductive and respiratory syndrome virus (PRRSv) in endemic settings: lessons learned in the U.S.
P2860
Q27006825-3EBD7C1F-58BE-4BC9-8FB2-497D152CDE67Q30547846-8A7295B9-DA5E-4733-8A26-EB54C68C62A9Q30830088-F32C9ED3-4B2F-4E72-9311-9106627C57A6Q33768736-DFB37873-FB84-439D-9377-53DE74FAF872Q33960664-AB8EB850-7BFC-4FB1-9171-BA07FDB802EBQ33998445-128669E9-5094-4897-B90A-4CFA8C065496Q34019891-4E8BF2D5-7E44-4646-88A4-5BAEE5FC8E63Q34121241-68CCC035-F4F3-467E-8FA2-EC2D8D83C44BQ34338486-B57F7ACE-0180-4C15-BAAB-F55797452448Q34766625-57B95C94-E18D-4284-A8FC-3D60F33636EEQ35122248-0AF962F1-EDB0-4BF9-A1FF-580ABE439735Q36288927-C18FF939-B365-45C7-93F4-2AA2F8A8B6D2Q36715877-3AC385A3-DF27-4B9D-B438-EADCB80415B0Q37203209-AAEB13C8-9B81-4AEF-8D51-4D87D4B78AD6Q37572027-5D135DF7-9724-475F-A230-DE662CDD1482Q37888528-19AA0C17-1A22-4216-9AE0-3F7B29737199Q38662110-721CD2AD-33A9-4E06-9DA8-17838A4D14FAQ38887093-D5FCB8EA-140A-4211-9BF6-DD306221A371Q39579222-57320B4B-E1F6-4CD2-B131-16DF4ABEF8ABQ39698430-E60411C4-D44F-492B-B568-749B426FD1FFQ39897389-EA516100-0A3C-4567-BE7C-3BA2AACE3A36Q40074901-68A5C901-E2F7-4BDB-8AD8-C0632E0562CEQ40422022-EECF5440-4DE9-45D9-B10C-5B4648516798Q40922501-8AF64E74-81D0-467B-9FBD-BCA712E81D77Q42004846-1733F083-A91A-44F9-B7E4-374BC7274F1EQ42085923-635BF6CF-356F-4740-BC40-7BD68A9C995EQ42596552-F794E844-E28E-413C-A492-13D636EECDBBQ44004089-14EE2E0C-5805-4A29-B783-E9504E4BD06CQ44781644-588D8488-D75B-4659-9599-7B3AD4B1C963Q50909265-59753EFF-4535-49B2-BF1E-D94899F75E4E
P2860
Seroneutralization of porcine reproductive and respiratory syndrome virus correlates with antibody response to the GP5 major envelope glycoprotein.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Seroneutralization of porcine ...... 5 major envelope glycoprotein.
@en
Seroneutralization of porcine ...... 5 major envelope glycoprotein.
@nl
type
label
Seroneutralization of porcine ...... 5 major envelope glycoprotein.
@en
Seroneutralization of porcine ...... 5 major envelope glycoprotein.
@nl
prefLabel
Seroneutralization of porcine ...... 5 major envelope glycoprotein.
@en
Seroneutralization of porcine ...... 5 major envelope glycoprotein.
@nl
P2093
P2860
P1476
Seroneutralization of porcine ...... 5 major envelope glycoprotein.
@en
P2093
P2860
P356
10.1177/104063879901100103
P577
1999-01-01T00:00:00Z